These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7327101)

  • 1. The role of dopaminergic and serotonergic mechanisms in the development of swimming ability of young rats.
    Tamásy V; Korányi L; Phelps CP
    Dev Neurosci; 1981; 4(5):389-400. PubMed ID: 7327101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain catecholamine concentration during the first week of development in rats.
    Phelps CP; Korányi L; Tamásy V
    Dev Neurosci; 1982; 5(5-6):503-7. PubMed ID: 7160315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apomorphine-induced inhibition of neostriatal activity is enhanced by lesions induced by 6-hydroxydopamine but not by long-term administration of amphetamine.
    Alloway KD; Rebec GV
    Neuropharmacology; 1984 Sep; 23(9):1033-9. PubMed ID: 6096755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and behavioural studies on the interference between catecholaminergic and serotonergic central systems.
    Allikmets LH; Zharkovsky AM
    Ann Ist Super Sanita; 1978; 14(1):63-70. PubMed ID: 40501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic activity of quipazine.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of destruction of midbrain raphe nuclei on the behavioral effects of dopaminergic substances and I-tryptophan].
    Allikmets LKh; Zharkovskiĭ AM; Arro AG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1977; 27(5):1030-5. PubMed ID: 563144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 1999 Dec; 34(3):228-40. PubMed ID: 10523760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine.
    Duncan GE; Criswell HE; McCown TJ; Paul IA; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1027-34. PubMed ID: 3121842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of serotonin and dopamine receptors in the mechanism of action of haloperidol and pirenperone].
    Maĭmets MO; Vasar EE; Nurk AM; Allikmets LKh
    Farmakol Toksikol; 1985; 48(2):15-8. PubMed ID: 3996566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circling behavior in normoxic or hypoxic rats with unilateral 6-OHDA nigrostriatal lesion. Part 1. Effects of apomorphine and L-dopa.
    Saligaut C; Daoust M; Moore N; Boismare F
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):219-24. PubMed ID: 3110513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of angiotensin on the central action of dopamine.
    Braszko J; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine.
    Yamawaki S; Lai H; Horita A
    J Pharmacol Exp Ther; 1983 Nov; 227(2):383-8. PubMed ID: 6631720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
    Heffner TG; Zigmond MJ; Stricker EM
    J Pharmacol Exp Ther; 1977 May; 201(2):386-99. PubMed ID: 859104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of amphetamine, methylphenidate, and apomorphine on regional brain serotonin and 5-hydroxyindole acetic acid.
    Kuczenski R; Segal DS; Leith NJ; Applegate CD
    Psychopharmacology (Berl); 1987; 93(3):329-35. PubMed ID: 2448842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of the dopamine and noradrenaline systems in regulating autogenic motor activity in rat pups].
    Timofeeva OP
    Zh Evol Biokhim Fiziol; 1989; 25(1):123-5. PubMed ID: 2728686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the participation of the dopaminergic system in the central effects of chelidonine.
    Kleinrok Z; Szponar J; Matuszek B; Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1990; 42(5):417-24. PubMed ID: 2098751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central dopamine receptors regulate blood eosinophilia in the rat.
    Podolec Z; Vetulani J; Bednarczyk B; Szczeklik A
    Allergy; 1979 Apr; 34(2):103-10. PubMed ID: 474944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.